You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Creyon Bio (branded Creyon) is a San Diego drug-development company operating an AI-powered nucleic acid engineering platform, NucleIQ, that designs oligonucleotide and RNA therapies with tissue- and cell-specific delivery.
Uncommon (uncommonbio.co, formerly Higher Steaks) is a Cambridge, UK biotechnology company backed by Balderton Capital. The company sold its cultivated meat platform to Vow and has pivoted to launch SymphoRNA, a new venture developing nucleic acid delivery technology for multi-RNA combination medicines that target complex diseases such as…
Hongene Biotech Corporation is a nucleic acid contract development and manufacturing organization (CDMO) founded in 1998, with nearly 30 years of RNA-focused expertise. It offers vertically integrated services spanning oligonucleotide API manufacturing (from preclinical to commercial, GMP up to tonne scale), mRNA CDMO services (raw materials…
Soufflé Therapeutics is a genetic medicine company developing nucleic acid (siRNA) therapeutics that use proprietary cell-specific ligand-conjugation technology to target and deliver treatments to specific cell types.